TrialInvestigational new drugs2006
A phase II trial of 17-(Allylamino)-17-demethoxygeldanamycin in patients with papillary and clear cell renal cell carcinoma.
Ellen A Ronnen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this papertrialcites it